Cocrystal Pharma, Inc. - FORM 8-K - EX-99.1 - AERO PHARMACEUTICALS, INC. AUDITED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2010 AND 2009 - May 19, 2011

Attached files

file filename
8-K - BIOZONE FORM 8-K 05/13/11 - Cocrystal Pharma, Inc.biozoneform8k051311.htm
EX-10.3 - BILL OF SALE - Cocrystal Pharma, Inc.biozoneex103.htm
EX-10.1 - ASSET PURCHASE AGREEMENT - Cocrystal Pharma, Inc.biozoneex101.htm
EX-10.2 - ASSIGNMENT AND ASSUMPTION AGREEMENT - Cocrystal Pharma, Inc.biozoneex102.htm
EX-21 - LIST OF SUBSIDIARIES - Cocrystal Pharma, Inc.biozoneex21.htm
EX-99.3 - PRESS RELEASE - Cocrystal Pharma, Inc.biozoneex993.htm
EX-10.11 - AMENDMENT NO.1 TO ASSET PURCHASE AGREEMENT DATED AS OF APRIL 25, 2011 BY AND BETWEEN AERO PHARMACEUTICALS, INC. AND TEVA RESPIRATORY, LLC - Cocrystal Pharma, Inc.biozoneex1011.htm
EX-99.2 - PRO FORMA UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2010 - Cocrystal Pharma, Inc.biozoneex992.htm
Exhibit 99.1
 
 
1
 
 
 
2
 
 
 
3
 
 
 
4
 
 
 
 
5
 
 
 
6
 
 
 
 
7
 
 
8
 
 
 
 
9
 
 
 
 
10
 
 
 
11
 
 
 
12
 
 
 
13
 
 
 
 
14
 
 
 
 
15
 
 
 
16
 
 
 
17
 
 
 
18
 
 
 
19
 
 
 
 
20
 
 
 
 
21
 
 
 
22
 
 
 
23
 
 
 
24
 
 
 
25
 
 
 
26
 
 
27

Cocrystal Pharma, Inc. Reports

Also read